Ag Novos Bioscience
Other, 7301 Calhoun Place Suite 100, Rockville, Maryland, 20855, United States, 11-50 Employees
Phone Number: 12*********
Who is AGNOVOS BIOSCIENCE
AgNovos Biocience is a developer of new therapies that leverage proprietary, bone-building technology and regenerative medicine to address unmet needs in the treatment of bone disease. Th...
Read More
-
Headquarters: 7301 Calhoun Place Suite 100, Rockville, Maryland, 20855, United States
-
Date Founded: 2012
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
SIC Code: 
Does something look wrong? Fix it. | View contact records from AGNOVOS BIOSCIENCE
AgNovos Bioscience Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding AgNovos Bioscience
Answer: AgNovos Bioscience's headquarters are located at 7301 Calhoun Place Suite 100, Rockville, Maryland, 20855, United States
Answer: AgNovos Bioscience's phone number is 12*********
Answer: AgNovos Bioscience's official website is https://agnovos.com
Answer: AgNovos Bioscience's revenue is $25 Million to $50 Million
Answer: AgNovos Bioscience's SIC: 3841
Answer: AgNovos Bioscience's NAICS: 339112
Answer: AgNovos Bioscience has 11-50 employees
Answer: AgNovos Bioscience is in Other
Answer: AgNovos Bioscience contact info: Phone number: 12********* Website: https://agnovos.com
Answer: AgNovos Biocience is a developer of new therapies that leverage proprietary, bone-building technology and regenerative medicine to address unmet needs in the treatment of bone disease. The Companys first product, the OSSURE Local Osteo-Enhancement Procedure (LOEP) kit has been evaluated in multiple clinical studies and is available in select markets. The Company has initiated RESTORE, a randomized, controlled, prospective, single-blinded, multi-national study designed to evaluate the impact of OSSURE LOEP on the risk of secondary hip fractures. RESTORE is one of the largest prospective studies ever conducted in orthopedic traumatology. The data generated will be critical to gaining access to new markets, including the U.S. and Japan. The Company has also developed the AGN1 LOEP SV kit investigational device intended to treat stable but painful vertebral compression fractures. That device has received both a Breakthrough Device designation and an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration. AgNovos Bioscience is privately held and has its corporate headquarters in New York City with manufacturing, research & development, and corporate support services located in Rockville, MD.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month